To investigate the clinical significance of FAT1 mutations in AML, we analyzed the clinical and molecular genetic characteristics of FAT1 mutant patients in both the LAML-KR cohort and the Venetoclax-AML cohort. The gene discussed is FAT1; the disease is acute myeloid leukemia.